Neuromed Raises $53.3M To Push Its Pain Program Aug. 22, 2007 By Trista Morrison Neuromed Pharmaceuticals Inc. closed a $53.3 million Series E financing, bringing the company's running total of venture capital raised to date to more than $126 million. (BioWorld Today)Read More
RSS